1. Chang, H. W., Jahng, Y., Selective cyclooxygenase-2 inhibitors as anti-inflammatory agents.J. Kor. Med. Chem., 8, 48–79 (1998), and references therein.
2. Giannangeli, M., Tomaselli, M., Pinza, M. Pharmaceutical compositions comprising diaryl-cyclomethylenepyrazole compounds and their use as cyclooxygenase II (COX II) inhibitors. WO, 9822442.
3. Graul, A., Martel, A. M., Castaner, J., Celecoxib, anti-inflammatory cyclooxygenase-2 inhibitor.Drugs of the Future, 22, 711–714 (1997).
4. Insel, P. A. InGoodmand and Gilman's The Pharmaceutical Basis of Therapeutics, 9th ed.; Hardman, J. G., Limbird, L. E.; Molinoff, P. B.; Ruddon, R. W., Gilman, A. G., eds., McGraw-Hill, New York, 617–658 (1996).
5. Jahng, Y. After submission of this paper, inhibitory activities of related 1,3-diaryl isomers were reported. Sui, Z., Guan, J., Ferro, M. P., McCoy, K., Wachter, M. P., Singer, M., Steber, M., Ritchie, D. M. Argentieri, D. C. 1,3-Diarylcycloalkaono[1,2-d]pyrazoles and diphenyl hydrazides as selective inhibitors of cyclo-oxygenase-2, 217th ACS National Meeting, Anaheim, CA, 1999, MEDI 202.